NCT00342498 is a clinical trial in Mutations, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Who is sponsoring NCT00342498?

NCT00342498 is sponsored by National Institute of Environmental Health Sciences (NIEHS).

What condition does NCT00342498 study?

NCT00342498 studies Mutations, Hormones.

Is NCT00342498 still recruiting?

NCT00342498 is currently completed. Last updated 2 July 2017.

Last reviewed 2017-07-02 · How we verify

NCT00342498

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Estrogen Receptor Gene Mutations

Completed Last updated 2 July 2017

What this trial tests

trial in Mutations. Completed in 17 June 2008.

Timeline

12 January 1994

17 June 2008

Quick facts

Lead sponsor	National Institute of Environmental Health Sciences (NIEHS)
Status	Completed
Study type	OBSERVATIONAL
Start date	12 January 1994
Estimated completion	17 June 2008
Sites	2 locations across United States

Conditions studied

Mutations — all drugs for Mutations →
Hormones — all drugs for Hormones →

Sponsor

National Institute of Environmental Health Sciences (NIEHS)

Who can join

18 and older, any sex, with Mutations or Hormones. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We propose to analyze a DNA sample for mutations in the estrogen receptor gene from a patient who appears insensitive to estrogen hormone treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mutations

Currently open trials in the same condition.

NCT07032727 — Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Act · Phase 2 · recruiting

Other National Institute of Environmental Health Sciences (NIEHS) trials

Trials by the same sponsor.

NCT07111065 — FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) · Phase 2 · recruiting
NCT06991751 — A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of C · not yet recruiting
NCT07437976 — A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity · not yet recruiting
NCT06325696 — H01 in Adults With Interstitial Lung Disease (The SOLIS Study) · Phase 2 · recruiting
NCT05666739 — NIEHS Repository of Stored Biological Samples for Future Use · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00342498 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Institute of Environmental Health Sciences (NIEHS)
Last refreshed: 2 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00342498.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing